Clinical Trial Update: An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer

View source ↗

Summary

An observational study evaluating the combination of YONDELIS (trabectedin) plus pegylated liposomal doxorubicin for platinum-sensitive recurrent ovarian cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)
• Yondelis (trabectedin)

Snippet

Sponsor: PharmaMar, Spain | Conditions: Recurrent Ovarian Cancer | Status: COMPLETED